NDC 0409-4235 – Docetaxel
Docetaxel 20 mg/mL · Injection, Solution · Intravenous
Product NDC0409-4235
Product details
- Brand name
- Docetaxel
- Generic name
- Docetaxel
- Labeler
- Hospira, Inc.
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- NDA · NDA022234
- Marketed since
- June 28, 2021
- Listing expires
- December 31, 2026
- Pharmacologic class
- Microtubule Inhibitor
Active ingredients
- Docetaxel 20 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0409-4235-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-4235-01) / 1 mL in 1 VIAL, SINGLE-DOSE | Jun 28, 2021 |
Other Docetaxel products
- 16729-267 Docetaxel Anhydrous 20 mg/mL · Injection, Solution, Concentrate · Accord Healthcare Inc.
- 45963-734 Docetaxel 20 mg/mL · Injection, Solution, Concentrate · Actavis Pharma, Inc.
- 45963-765 Docetaxel 20 mg/mL · Injection, Solution, Concentrate · Actavis Pharma, Inc.
- 62332-678 Docetaxel Anhydrous 10 mg/mL · Injection · Alembic Pharmaceuticals Inc.
- 46708-678 Docetaxel Anhydrous 10 mg/mL · Injection · Alembic Pharmaceuticals Limited
- 70121-1222 Docetaxel Anhydrous 80 mg/4mL · Injection · Amneal Pharmaceuticals LLC
- 70121-1221 Docetaxel Anhydrous 20 mg/mL · Injection · Amneal Pharmaceuticals LLC
- 70121-1223 Docetaxel Anhydrous 160 mg/8mL · Injection · Amneal Pharmaceuticals LLC
- 43066-048 Docetaxel Anhydrous 10 mg/mL · Injection · Baxter Healthcare Corporation
- 43066-010 Docetaxel 10 mg/mL · Injection, Solution · Baxter Healthcare Corporation
- 43066-046 Docetaxel Anhydrous 10 mg/mL · Injection · Baxter Healthcare Corporation
- 43066-044 Docetaxel Anhydrous 10 mg/mL · Injection · Baxter Healthcare Corporation